gadolinium dtpa has been researched along with 68ga-dotanoc in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (68ga-dotanoc) | Trials (68ga-dotanoc) | Recent Studies (post-2010) (68ga-dotanoc) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 183 | 7 | 157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ba-Ssalamah, A; Eidherr, H; Herneth, A; Karanikas, G; Mayerhoefer, ME; Mitterhauser, M; Raderer, M; Trattnig, S; Wadsak, W; Weber, M | 1 |
1 other study(ies) available for gadolinium dtpa and 68ga-dotanoc
| Article | Year |
|---|---|
Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Child; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium DTPA; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2013 |